Total Payments
$1,832
2024 Payments
$183.23
Companies
16
Transactions
117
Medicare Patients
17,511
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$1,711 (93.4%)
Education$120.72 (6.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,711 | 115 | 93.4% |
| Education | $120.72 | 2 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $332.03 | 26 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $307.02 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $301.09 | 22 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $208.34 | 8 | $0 (2023) |
| GENZYME CORPORATION | $206.91 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $95.60 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $75.87 | 5 | $0 (2024) |
| LEO Pharma Inc. | $50.77 | 2 | $0 (2023) |
| Incyte Corporation | $44.59 | 3 | $0 (2024) |
| PFIZER INC. | $44.42 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $183.23 | 10 | ABBVIE INC. ($34.11) |
| 2023 | $999.55 | 65 | Novartis Pharmaceuticals Corporation ($182.41) |
| 2022 | $455.70 | 33 | ABBVIE INC. ($128.82) |
| 2021 | $146.59 | 6 | Regeneron Healthcare Solutions, Inc. ($89.22) |
| 2020 | $34.00 | 2 | Regeneron Healthcare Solutions, Inc. ($19.94) |
| 2019 | $12.73 | 1 | Almirall LLC ($12.73) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Inflammation | ||||||
| 02/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: DERMATOLOGY | ||||||
| 02/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 02/09/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $15.84 | General |
| 02/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: Dermatology | ||||||
| 02/02/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.04 | General |
| Category: Dermatology | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Dermatology | ||||||
| 01/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: IMMUNOLOGY | ||||||
| 01/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| Category: Immunology | ||||||
| 12/20/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $32.47 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Immunology | ||||||
| 12/15/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $29.35 | General |
| 12/13/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Dermatology | ||||||
| 12/13/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Dermatology | ||||||
| 12/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/07/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.69 | General |
| Category: Immunology | ||||||
| 12/05/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $14.40 | General |
| 12/05/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $12.00 | General |
| 11/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $47.99 | General |
| Category: Immunology | ||||||
| 11/14/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 4,180 | 8,433 | $955,997 | $292,227 |
| 2022 | 20 | 4,391 | 8,783 | $961,436 | $286,821 |
| 2021 | 18 | 4,431 | 8,595 | $972,272 | $311,830 |
| 2020 | 20 | 4,509 | 8,988 | $960,891 | $310,363 |
Total Patients
17,511
Total Services
34,799
Medicare Billing
$1.2M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 861 | 1,194 | $223,039 | $72,481 | 32.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 655 | 811 | $179,134 | $51,363 | 28.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 199 | 273 | $95,026 | $32,295 | 34.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 335 | 650 | $72,501 | $24,826 | 34.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 281 | 328 | $79,061 | $24,365 | 30.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 572 | 725 | $100,268 | $22,642 | 22.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 502 | 3,527 | $48,955 | $17,415 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 176 | $46,622 | $16,254 | 34.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 132 | 132 | $30,215 | $9,641 | 31.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 192 | 206 | $23,847 | $5,066 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,544 | $3,053 | 32.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 23 | 30 | $8,429 | $2,688 | 31.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 22 | $8,236 | $2,452 | 29.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 47 | 60 | $7,079 | $1,770 | 25.0% |
| 69100 | Biopsy of ear | Office | 2023 | 34 | 38 | $8,032 | $1,758 | 21.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 41 | 41 | $6,376 | $1,504 | 23.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 15 | 15 | $3,867 | $1,201 | 31.0% |
| 10040 | Acne surgery | Office | 2023 | 16 | 16 | $3,932 | $1,120 | 28.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 24 | $1,031 | $236.93 | 23.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 60 | 137 | $804.19 | $97.45 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 756 | 1,032 | $192,768 | $58,165 | 30.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 646 | 797 | $176,041 | $50,202 | 28.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 660 | 893 | $123,502 | $29,885 | 24.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 290 | 357 | $86,051 | $26,305 | 30.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 159 | 213 | $74,141 | $25,223 | 34.0% |
About Dr. Christopher Jones, M.D
Dr. Christopher Jones, M.D is a Dermatology healthcare provider based in Cedar Park, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013122753.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Jones, M.D has received a total of $1,832 in payments from pharmaceutical and medical device companies, with $183.23 received in 2024. These payments were reported across 117 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,711).
As a Medicare-enrolled provider, Jones has provided services to 17,511 Medicare beneficiaries, totaling 34,799 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Cedar Park, TX
- Active Since 05/14/2007
- Last Updated 04/28/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013122753
Products in Payments
- Winlevi (Drug) $273.49
- DUPIXENT (Biological) $216.49
- SKYRIZI (Biological) $175.89
- COSENTYX (Drug) $174.77
- RINVOQ (Biological) $156.14
- COSENTYX (Biological) $96.92
- TREMFYA (Drug) $95.60
- Sotyktu (Drug) $75.87
- ADBRY (Biological) $50.77
- OPZELURA (Drug) $44.59
- EUCRISA (Drug) $44.42
- ILUMYA (Biological) $33.53
- YCANTH (Drug) $32.47
- Otezla (Drug) $32.36
- LIBTAYO (Biological) $22.94
- AMELUZ (Drug) $20.14
- Cimzia (Drug) $14.71
- Bimzelx (Biological) $13.72
- Seysara (Drug) $12.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Cedar Park
Aubrey Hartmann, Md, MD
Dermatology — Payments: $164,879
Dermatology $164,879
Dr. Hubert Chodkiewicz, M.d, M.D
Dermatology — Payments: $12,630
Dermatology $12,630
Dr. Donna Hart, M.d, M.D
Dermatology — Payments: $11,413
Dermatology $11,413
Jessica Dorsey, Md, MD
Dermatology — Payments: $10,153
Dermatology $10,153
Christopher Dallo, Md, MD
Dermatology — Payments: $3,250
Dermatology $3,250
Shwol-Huo Kiang, Do, DO
Dermatology — Payments: $3,011
Dermatology $3,011